Circulating tumor-derived biomarkers in lung cancer.

@article{Taenzer2012CirculatingTB,
  title={Circulating tumor-derived biomarkers in lung cancer.},
  author={Aline Taenzer and Catherine Alix-Panabi{\`e}res and Harriet Wikman and Klaus Pantel},
  journal={Journal of thoracic disease},
  year={2012},
  volume={4 5},
  pages={
          448-9
        }
}
The NIH Biomarkers Definition Working Group defined a biomarker as “a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacological responses to a therapeutic intervention” (1). In lung cancer, an enormous research effort is underway related to biomarkers in airway epithelial cells, sputum, breath, urine and blood for early diagnosis or prediction of high risk. Here, we will focus on blood as the source of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references